TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that pursuant to an agreement with a collaboration partner entered November 18, 2015, it has agreed to co-develop a portfolio of niche products that will be sold on the TruPharma label. The products and the partner are confidential pending FDA approval of the ANDAs. TruPharma expects the first two products that are subject to the agreement to be submitted to FDA in 2016.